Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 1, 2014, Pages 55-60

  Kaya, Ahmet ^a   Tanboǧa, Ibrahim Halil ^b   Kurt, Mustafa ^c   Işik, Turgay ^c   Kaya, Yasemin ^c   Günaydin, Zeki Yüksel ^a   Aksakal, Enbiya ^b  

^a ORDU UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c Erzurum Education and Research Hospital   (Turkey)

Author keywords

ABO blood group; Coronary artery disease; Multiple logistic regression analysis; SYNTAX score

Indexed keywords

BLOOD GROUP ABO SYSTEM;

BLOOD; BLOOD GROUP ABO SYSTEM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; HUMAN; PATHOLOGY; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ABO BLOOD-GROUP SYSTEM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; LOGISTIC MODELS; SEVERITY OF ILLNESS INDEX;

EID: 84894581151     PISSN: None     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2013.4728     Document Type: Article

References (39)

1. Libby P, Ridker PM, Hansson GK. Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-2138.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
3. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485.
4. Marenberg ME, Risch N, Berkman L F, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-1046.
5. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007; 58: 513-522.
6. Sari İ, Özer O, Davutoǧlu V, Görgülü S, Eren M, Aksoy M. ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial infarction. Blood Coagul Fibrinolysis 2008; 19: 231-234.
7. Franchini M, Capra F, Targher G, Montagnana M, Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007; 5: 14.
8. ÒDonnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335-341.
9. Biancari F, Satta J, Pokela R, Juvonen T. ABO blood group distribution and severity of coronary artery disease among patients undergoing coronary artery bypass surgery in Northern Finland. Thromb Res 2002; 108: 195-196.
10. Sianos G, Morel MA, Kappetein A P, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
11. Tanboǧa IH, Ekinci M, Işik T, Kurt M, Kaya A, Sevimli S. Reproducibility of SYNTAX score: from core lab to real world. J Interv Cardiol 2011; 24: 302-306.
12. Aksakal E, Tanboǧa IH, Kurt M, Kaya A, Topçu S, Kalkan K, et al. Predictors of coronary lesions complexity in patients with stable coronary artery disease. Angiology 2013; 64: 304-309.
13. Serruys PW, Morice MC, Kappetein A P, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
14. Aksakal E, Tanboǧa IH, Kurt M, Kaygin MA, Kaya A, Işik T, et al. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis 2012; 221: 596-601.
15. SYNTAX working-group. SYNTAX score calculator: Available at URL: www.syntaxscore.com. Accessed date at September 2012.
16. Schmitz G, Kaminski WE. ABCA2: a candidate regulator of neural transmembrane lipid transport. Cell Mol Life Sci 2002; 59:1285-1295.
17. Carpeggiani C, Coceani M, Landi P, Michelassi C, L'Abbate A. ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010; 211: 461-466.
18. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-69.
19. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904.
20. Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006; 4: 1186-1193.
21. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998; 18: 1359-1362.
22. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424.
23. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-1108.
24. Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999; 94: 172-178.
25. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-1695.
26. Preston AE, Barr A. The Plasma Concentration of Factor Viii in the Normal Population. II. The Effects of Age, Sex and Blood Group. Br J Haematol 1964; 10: 238-245.
27. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
28. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92.
29. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219-4225.
30. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010; 19: 1863-1872.
31. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008; 4: e100-e118.
32. Kiechl S, Pare G, Barbalic M, Qi L, Dupuis J, Dehghan A, et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011; 4: 681-686.
33. Nydegger UE, Wuillemin WA, Julmy F, Meyer BJ, Carrel T P. Association of ABO histo-blood group B allele with myocardial infarction. Eur J Immunogenet 2003; 30: 201-206.
34. Garrison RJ, Havlik RJ, Harris RB, Feinleib M, Kannel WB, Padgett SJ. ABO blood group and cardiovacular disease: the Framingham study. Atherosclerosis 1976; 25: 311-318.
35. Lee H F, Lin YC, Lin C P, Wang CL, Chang CJ, Hsu LA. Association of blood group A with coronary artery disease in young adults in Taiwan. Intern Med 2012; 51: 1815-1820.
36. He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012; 32: 2314-2330.
37. Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Darabian C, Goodarzynejad H. Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol 2006; 110: 256-8.
38. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998; 38: 975-988.
39. Reilly M P, Li M, He J, Ferguson J F, Stylianou IM, Mehta NN, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377: 383-392.